TG Therapeutics Inc (TGTX)
13.79
-0.20
(-1.43%)
USD |
NASDAQ |
Apr 19, 16:00
13.79
0.00 (0.00%)
After-Hours: 17:51
TG Therapeutics Cash and Short Term Investments (Quarterly): 217.51M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 217.51M |
| September 30, 2023 | 150.90M |
| June 30, 2023 | 144.90M |
| March 31, 2023 | 139.71M |
| December 31, 2022 | 161.68M |
| September 30, 2022 | 175.94M |
| June 30, 2022 | 195.71M |
| March 31, 2022 | 233.20M |
| December 31, 2021 | 314.76M |
| September 30, 2021 | 356.85M |
| June 30, 2021 | 443.46M |
| March 31, 2021 | 523.85M |
| December 31, 2020 | 605.43M |
| September 30, 2020 | 254.15M |
| June 30, 2020 | 275.57M |
| March 31, 2020 | 78.34M |
| December 31, 2019 | 140.44M |
| September 30, 2019 | 72.45M |
| June 30, 2019 | 84.98M |
| March 31, 2019 | 92.47M |
| December 31, 2018 | 68.90M |
| September 30, 2018 | 97.74M |
| June 30, 2018 | 126.24M |
| March 31, 2018 | 109.08M |
| December 31, 2017 | 84.72M |
| Date | Value |
|---|---|
| September 30, 2017 | 91.84M |
| June 30, 2017 | 86.41M |
| March 31, 2017 | 109.46M |
| December 31, 2016 | 44.89M |
| September 30, 2016 | 60.60M |
| June 30, 2016 | 54.26M |
| March 31, 2016 | 58.70M |
| December 31, 2015 | 77.23M |
| September 30, 2015 | 94.16M |
| June 30, 2015 | 92.07M |
| March 31, 2015 | 105.14M |
| December 31, 2014 | 78.78M |
| September 30, 2014 | 67.24M |
| June 30, 2014 | 45.04M |
| March 31, 2014 | 53.50M |
| December 31, 2013 | 40.49M |
| September 30, 2013 | 50.18M |
| June 30, 2013 | 13.42M |
| March 31, 2013 | 15.19M |
| December 31, 2012 | 16.46M |
| September 30, 2012 | 17.37M |
| June 30, 2012 | 20.37M |
| March 31, 2012 | 20.92M |
| December 31, 2011 | 9.748M |
| September 30, 2011 | 0.2123M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
72.45M
Minimum
Sep 2019
605.43M
Maximum
Dec 2020
240.52M
Average
195.71M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 286.20M |
| Geron Corp | 333.70M |
| Editas Medicine Inc | 323.11M |
| G1 Therapeutics Inc | 82.16M |
| Mersana Therapeutics Inc | 209.08M |